Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

93 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Multisite controlled study of OROS methylphenidate in the treatment of adolescents with attention-deficit/hyperactivity disorder.
Wilens TE, McBurnett K, Bukstein O, McGough J, Greenhill L, Lerner M, Stein MA, Conners CK, Duby J, Newcorn J, Bailey CE, Kratochvil CJ, Coury D, Casat C, Denisco MJ, Halstead P, Bloom L, Zimmerman BA, Gu J, Cooper KM, Lynch JM. Wilens TE, et al. Among authors: mcburnett k. Arch Pediatr Adolesc Med. 2006 Jan;160(1):82-90. doi: 10.1001/archpedi.160.1.82. Arch Pediatr Adolesc Med. 2006. PMID: 16389216 Clinical Trial.
ADHD treatment with once-daily OROS methylphenidate: interim 12-month results from a long-term open-label study.
Wilens T, Pelham W, Stein M, Conners CK, Abikoff H, Atkins M, August G, Greenhill L, McBurnett K, Palumbo D, Swanson J, Wolraich M. Wilens T, et al. Among authors: mcburnett k. J Am Acad Child Adolesc Psychiatry. 2003 Apr;42(4):424-33. doi: 10.1097/01.CHI.0000046814.95464.7D. J Am Acad Child Adolesc Psychiatry. 2003. PMID: 12649629 Clinical Trial.
Distinguishing the efficacy and sedative effects of guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder.
Huss M, McBurnett K, Cutler AJ, Hervás A, Bliss C, Gao J, Dirks B, Newcorn JH. Huss M, et al. Among authors: mcburnett k. Eur Neuropsychopharmacol. 2019 Mar;29(3):432-443. doi: 10.1016/j.euroneuro.2018.05.012. Epub 2018 Jul 29. Eur Neuropsychopharmacol. 2019. PMID: 30064718 Free article. Clinical Trial.
93 results